In single-center study, GLP-1 use in people with type 1 diabetes was associated with lower hospitalization rates.

The study highlights early microvascular impairment in adolescents with type 1 diabetes, emphasizing the importance of monitoring vascular health in this group.

Biomea Fusion (NASDAQ:BMEA) executives highlighted early, exploratory clinical data for icovamenib in type 1 diabetes, presenting top-line results from the company’s COVALENT-112 proof-of-concept ...

New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) suggests that living in a rural environment ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of Type 1 diabetes by targeting an inflammation-related protein ...

Please provide your email address to receive an email when new articles are posted on . Adults are 1.64 times more likely to develop type 1 diabetes if their father has type 1 diabetes rather than ...

A combination blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely ...

Your early life may quietly set the stage for developing Type 1 diabetes, an increasingly common, lifelong condition that can ...

New INTIMET study finds metformin helps people with type 1 diabetes reduce insulin needs by 12 per cent without affecting ...

How Does Tzield Work in Type 1 Diabetes? Type 1 diabetes is an autoimmune disease in which your immune system mistakenly attacks and damages the beta cells in your pancreas. The beta cells produce ...